ARID1A and endometrium neoplasm: An early functional proteogenomic analysis of endometrial tumor samples with ARID1A mutations using reverse phase protein array demonstrates that ARID1A mutations often co-occur with mutations in the PI3K pathway and are related to PI3K pathway activation.